Buckner JC - Search Results

1

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF. Sarkaria JN, et al. Among authors: buckner jc. Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175. Neuro Oncol. 2018. PMID: 29016900 Free PMC article. Review.

2

Cisplatin-based chemotherapy in primary central nervous system germ cell tumors.

Patel SR, Buckner JC, Smithson WA, Scheithauer BW, Groover RV. Patel SR, et al. Among authors: buckner jc. J Neurooncol. 1992 Jan;12(1):47-52. doi: 10.1007/BF00172456. J Neurooncol. 1992. PMID: 1541978

3

Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.

Elliott TE, Buckner JC, Cascino TL, Levitt R, O'Fallon JR, Scheithauer BW. Elliott TE, et al. Among authors: buckner jc. J Neurooncol. 1991 Feb;10(1):27-30. doi: 10.1007/BF00151244. J Neurooncol. 1991. PMID: 1902506

4

Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma.

Buckner JC, Brown LD, Cascino TL, Gerstner JB, Krook JE, Westberg MW, Wiesenfeld M, O'Fallon JR, Scheithauer B. Buckner JC, et al. J Neurooncol. 1990 Dec;9(3):249-54. J Neurooncol. 1990. PMID: 2086739 Clinical Trial.

5

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.

Cascino TL, Veeder MH, Buckner JC, O'Fallon JR, Wiesenfeld M, Levitt R, Goldberg RM, Kuross SA, Morton RF, Scheithauer BW. Cascino TL, et al. Among authors: buckner jc. J Neurooncol. 1996 Dec;30(3):243-6. doi: 10.1007/BF00177275. J Neurooncol. 1996. PMID: 8943099 Clinical Trial.

6

Effective chemotherapy for advanced CNS embryonal tumors in adults.

Galanis E, Buckner JC, Schomberg PJ, Hammack JE, Raffel C, Scheithauer BW. Galanis E, et al. Among authors: buckner jc. J Clin Oncol. 1997 Aug;15(8):2939-44. doi: 10.1200/JCO.1997.15.8.2939. J Clin Oncol. 1997. PMID: 9256138

7

Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma.

Buckner JC, Burch PA, Cascino TL, O'Fallon JR, Scheithauer BW. Buckner JC, et al. J Neurooncol. 1998 Jan;36(1):65-70. doi: 10.1023/a:1005870329601. J Neurooncol. 1998. PMID: 9525827 Clinical Trial.

8

Management of recurrent meningeal hemangiopericytoma.

Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG. Galanis E, et al. Among authors: buckner jc. Cancer. 1998 May 15;82(10):1915-20. Cancer. 1998. PMID: 9587125 Clinical Trial.

9

Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.

Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, O'Fallon JR, Farr G Jr. Galanis E, et al. Among authors: buckner jc. J Neurosurg. 1998 Sep;89(3):425-30. doi: 10.3171/jns.1998.89.3.0425. J Neurosurg. 1998. PMID: 9724117 Clinical Trial.

10

Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.

Galanis E, Buckner J, Kimmel D, Jenkins R, Alderete B, O'Fallon J, Wang CH, Scheithauer BW, James CD. Galanis E, et al. Int J Oncol. 1998 Oct;13(4):717-24. Int J Oncol. 1998. PMID: 9735401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page